A. Kastrup et al., NO EFFECT OF PROPHYLACTIC TREATMENT WITH METOPROLOL ON CEREBROVASCULAR CO2 REACTIVITY IN MIGRAINEURS, Cephalalgia, 18(6), 1998, pp. 353-357
The prophylactic effect of metoprolol in the treatment of migraine is
well known, but its mode of action is still unclear. In the past, incr
eased CO2 reactivity has been reported as one pathognomic finding in i
nterictal migraineurs. Using transcranial Doppler we assessed CO2 reac
tivity in 20 migraineurs before and 3 h after the first intake of 50 m
g metoprolol, and subsequently twice after 1 and 8 weeks of continuous
therapy with 150 mg metoprolol/d. Before initiation of therapy, migra
ineurs as a group had increased CO2 reactivity (p=0.07) compared to 20
age- and sex-matched volunteers. While treatment with metoprolol has
been reported to affect amplitudes of increased contingent negative va
riation or visual evoked potentials in interictal migraineurs, it had
no influence on enhanced CO2 reactivity in the present study. Moreover
, the pretreatment value of CO2 reactivity did not correlate with the
clinical efficacy of metoprolol after a 2-month treatment period.